0000000000605824

AUTHOR

Jean Dupouy-camet

showing 2 related works from this author

Perspectives for parasitology and parasitology networks in Europe

2009

This article describes networks of parasitologists in Europe. Some research networks are supported by the European Commission within highly diverse framework programs. The European Federation of Parasitologists aims to promote the exchange of knowledge and the coordination of research in the fields of basic, veterinary and medical parasitology, particularly via meetings (e.g. the European Multicolloquium of Parasitology) that offer an unparalleled opportunity to assess the development of the discipline on the continent. The present situation is discussed here and some perspectives are proposed.

EuropeVeterinary medicineInfectious DiseasesVeterinary parasitologyParasitologyPolitical scienceAnimalsParasitologyEngineering ethicsEuropean commissionEuropean UnionSocieties MedicalTrends in Parasitology
researchProduct

Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19

2020

Our coalition of public health experts, doctors, and scientists worldwide want to draw attention to the need for high-quality evaluation protocols of the potential beneficial effect of hydroxychloroquine (HCQ) as a post-exposure drug for exposed people. In the absence of an approved, recognized effective pre or post-exposure prophylactic drug or vaccine for COVID-19, nor of any approved and validated therapeutic drug, coupled with social and political pressure raised by publicity both regarding the potential beneficial effect of hydroxychloroquine (HCQ) as well as potential risks from HCQ, we urge the immediate proper clinical trials. Specifically, we mean using HCQ for post-exposure of peo…

Drugmedicine.medical_specialtyPost exposureCoronavirus disease 2019 (COVID-19)COVID19media_common.quotation_subject030231 tropical medicineHydroxychloroquine ; COVID-19 ; Chloroquine ; SARS-CoV2 ; antiviral ; malaria ; Systemic lupus erythematosus ; Immunomodulation ; CoronavirusLoading doseImmunomodulation03 medical and health sciencesSystemic lupus erythematosus0302 clinical medicineChloroquineInternal medicineMedicine030212 general & internal medicineCoronavirus malaria antiviralmedia_commonlcsh:R5-920business.industryStandard treatmentPublic Health Environmental and Occupational HealthChloroquineHydroxychloroquineClinical trialEditorialInfectious DiseasesSARS-CoV2lcsh:Medicine (General)businessHydroxychloroquinemedicine.drugOne Health
researchProduct